Elite Pharmaceuticals Awarded Second U.S. Patent for Abuse Resistant Drug Formulation
23. April 2013 08:23 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 23, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the issuance of U.S. Patent No. 8,425,933 entitled...